The FDA has granted Abeona Therapeutics Fast Track status to the Gene Therapy trial to treat Sanfilippo Syndrome Type IIIA.
You are here: Home / News / Abeona Therapeutics Announces Fast Track Designation from FDA for ABO-102 in Sanfilippo Syndrome Type A